Psoriasis Clinical Trial

Excimer Laser, Serum Markers & Psoriasis

Summary

The overall aims for this study are to determine whether UVB excimer laser treatment of psoriasis affects serum inflammatory markers, and to assess hyperpigmentation and erythema with excimer laser treatment.

The investigators hypothesize that treatment of psoriasis with UVB delivered via 308 nm excimer laser will decrease the levels of serum inflammatory markers. The investigators hypothesize that treatment will decrease plaque erythema and will result in minimal hyperpigmentation.

View Full Description

Full Description

Subjects will undergo Excimer treatment twice a week until they reach a PASI 75 improvement, or until they reach the maximum of 20 total treatments. A blood draw to assess serum inflammatory markers will be performed at the screening visit and final visit. Chromameter assessment, photographs, PASI and PGA (Physician Global Assessment) will be performed throughout the study to monitor psoriasis improvement, hyperpigmentation and erythema.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age 18 years and older
Male or female with diagnosis of psoriasis
Psoriasis involvement of 5-15% BSA
Has been off systemic psoriasis therapies (e.g. retinoids, methotrexate, biologic agents, etc) for at least 4 weeks
Has been off topical therapies (e.g. calcipotriene, topical steroids) for at least 2 weeks
Fitzpatrick Skin Types I-VI

Exclusion Criteria:

Active history of photosensitivity (e.g. xeroderma pigmentosum, lupus erythematosus, porphyria, severe polymorphous light eruption, solar urticaria)
Any suspicion that the psoriasis is of the photosensitive variant.
Any medical condition that could be aggravated or may cause extreme discomfort during the study period.

Study is for people with:

Psoriasis

Study ID:

NCT02165657

Recruitment Status:

Withdrawn

Sponsor:

University Hospitals Cleveland Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University Hospitals Cleveland Medical Center (Concord Site)
Concord Ohio, 44077, United States

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Study ID:

NCT02165657

Recruitment Status:

Withdrawn

Sponsor:


University Hospitals Cleveland Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider